FirsthandHealth
medRxiv PreprintsInternational15 November 2026

In-country cerebrospinal fluid metagenomic next generation sequencing for pathogen detection in Lima, Peru

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Background: Central nervous system (CNS) infections are a major cause of morbidity and mortality in low- and middle-income countries such as Peru. However, their epidemiology is poorly characterized due to a wide range of endemic and opportunistic pathogens involved and limited access to specialized neurodiagnostic testing. Cerebrospinal fluid (CSF) metagenomic next-generation sequencing (mNGS) can detect any pathogen in a single hypothesis-free assay but has largely been confined to reference laboratories in high-income countries due to high cost and infrastructure requirements. We piloted an
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.